tracking microbicide funding

Similar documents
$3,203m 73% Global investment in. neglected disease R&D. $420m Funding to PDPs

Solicitation and Referral of Grant Applications at the NCI

Grants given directly to researchers and developers: $1,849m (76%) Grants given to other intermediaries: $69m (2.8%)

2017 NIH Update. Presented by Stephanie Smith and Stacey Wade

Behavioral and Social Sciences Research at the National Institutes of Health

Jennifer Ibrahim, PhD, MPH Associate Professor College of Health Professions and Social Work, Temple University

How to Write a Successful NIH Career Development Award (K Award) Mark H. Roltsch, PhD Assistant Vice President for Research Director of RSP

Overview of the NIH Career Development Programs

Early Stage Investigators and the Program Perspective

Fostering New Researchers at NIH

Generosity of R&D Tax Incentives

FY 2019 Appropriations Update: Senate Appropriations Committee Approves Labor, Health and Human Services, Education Bill

Introduction to the NIH and the Grant Writing Process

Organizational Development (OD)

The Global Fund to Fight AIDS, Tuberculosis and Malaria

NIH Mission Improve human health through biomedical and behavioral research, research training and communications.

Giving in Europe. The state of research on giving in 20 European countries. Barry Hoolwerf and Theo Schuyt (eds.)

Optimizing Your Research Agenda in Tissue Engineering

The NIH AREA Program The CUR Dialogues Washington, DC February 26, 2010

IHRTP Grant Mentoring 13 January International Funding Opportunities for Health Researchers

DREF Operation update Mali: Preparedness for Ebola

NIH FACULTY DIRECTORY

v Searching NIH award data for a study section and other key information

Deadline Amount/# yrs Award & Organization Format of Proposal Details Nov 11, st year. 2 page proposal 100,000USD

Conceptual and Practical Issues in Funding through the National Institutes of Health: The Example of Cancer Control

The National Institutes of Health (NIH): Organization, Funding, and Congressional Issues

Summary and Analysis of the President s FY 2012 Budget Request for Federal Research and Education Programs

CRS Report for Congress

American Reinvestment and Recovery Act of 2009 Office of Policy for Extramural Research Administration

Grantee Perception Report. Prepared for Ford Foundation November 2017

Alliance of Technology Transfer Professionals

OPCW UN JOINT MISSION IN SYRIA

Overview on diabetes policy frameworks in the European Union and in other European countries

Academic Research Enhancement Award (AREA) Program

THE ROLE OF INTERNATIONAL, REGIONAL & SUB-REGIONAL INSTITUTIONS IN SUPPORTING SD IN THE ARAB REGION

TOWARDS COLLABORATIVE SUPPORT

NIH Grant Categories. The following donated presentation offers succinct definitions of the variety of NIH Grant types and their distribution

Ireland Future R&D Investment in a Small Open Economy Opportunities and Threats. Third KEI Workshop Helsinki

GLOBAL GRANTS BREAKDOWN. 1.2 million Rotary Members. A rating from Charity Watch, ,000 Rotary Clubs

Measuring R&D in the Nonprofit Sector: The European Experience

A N N U A L R E P O R T F H I O R G / A N N U A L - R E P O R T

Taiwan s s Healthcare Industry. Taiwan Institute of Economic Research Dr. Julie C. L. SUN 16 January 2007

A European workforce for call centre services. Construction industry recruits abroad

The Maritime Alliance & International BlueTech Collaboration

Participation Statistics of EU-based Researchers in U.S. National Programmes

First Meeting of the Investment Action Group of the Global Alliance for Climate Smart Agriculture (GACSA) Participants Documents to read in advance

FOHNEU and THE E UR OPEAN DIME NS ION. NANTES FR ANC E 7-9 NOVEMB ER 2007 Julie S taun

Africa Call Projects and Clusters Analysis of Potential Funding and Implementing Programmes

Joint Research Funding Opportunities

Implementation of the System of Health Accounts in OECD countries

U.S. Funding for International Maternal & Child Health

Erasmus+: Knowledge Alliances and Sector Skills Alliances. Infoday. 23 November María-Luisa García Mínguez, Renata Russell (EACEA) 1

OPCW UN JOINT MISSION IN SYRIA

Compensation. Benefits. Expatriation.

Erasmus+ Benefits for Erasmus+ Students

EDCTP2 - Opportunities for clinical research on poverty-related diseases in sub-saharan Africa.

A UNIVERSAL PATHWAY. A WOMAN S RIGHT TO HEALTH

EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organisations

O P P O R T U N I T I E S ( O D A & F O U N D A T I O N S / P H I L A N T H R O P I E S )

Foreign contributions received between July and September, 2017

Information Erasmus Erasmus+ Grant for Study and/or Internship Abroad

THE NATIONAL INVESTMENT IN RESEARCH. Professor Vicki Sara Chair, Australian Research Council

CIHI Your Partner in Health Research

Excerpts from the IFHRO Handbook on Health Record Education

OVERVIEW OF HEALTH WORKFORCE PROJECTION MODELS IN 18 OECD COUNTRIES. Gaetan Lafortune Senior Economist, OECD Health Division

Defence Expenditure of NATO Countries ( )

Equal Distribution of Health Care Resources: European Model

Agenda item for discussion IPDC fundraising and communication

Career development (K award) grants

Developing and Submitting an NIH Grant Application

Exploiting International Life Science Opportunities. Dafydd Davies

Q Manpower. Employment Outlook Survey Global. A Manpower Research Report

***** 13 February 2018 *****

***** 2 October 2018 (pre-ministerial day) *****

ERA-Can+ twinning programme Call text

Insights into NIH Funding of Hydrocephalus Research. Paul Gross Chairman, Hydrocephalus Association

The Ploughshares Monitor

Remaking Health Care in America

RESOURCE MOBILIZATION PLAN International Bureau of Education (IBE)

How to Find RFPs That Meet Your Needs: Successful Grant Research.

U.S. Funding for International Nutrition Programs

Tri-Agency Data Management Policy Initiative. Matthew Lucas, PhD. Social Sciences and Humanities Research Council.

ACHIEVING PATIENT-CENTRED HEALTHCARE THANKS TO PATIENTS ORGANIZATIONS

EUREKA An Exceptional Opportunity to extend Canadian company reach to Europe, Israel and South Korea

How Will Europe s New Medtech Code Affect Your Meetings?

First quarter of 2014 Euro area job vacancy rate up to 1.7% EU28 up to 1.6%

ITU Statistical Activities

CONCLUDING ACT OF THE NEGOTIATION ON PERSONNEL STRENGTH OF CONVENTIONAL ARMED FORCES IN EUROPE

Partnerships to Address Global Product Safety in Public Health. Dr. Katherine Bond November 18, 2014

I-Corps at NIH 11/14/2017. Lili Portilla, MPA. Director, Office of Strategic Alliance November 8, Participating ICs in 2018

DBQ 20: THE COLD WAR BEGINS

Rank Name of School Score Country. 8 University of Michigan Ann Arbor United States. 9 Texas A&M University 200.

The EUREKA Initiative. Matteo Fedeli EUREKA Secretariat

ITU World Telecommunication Development Report. Access Indicators for the Information Society. Press Briefing UN, Geneva 4 December 2003

Hospital Standardized Mortality Ratios, Edmonton, Canada: A Tale of Two Sites Lessons Learned from the UK

Supporting Syria and the region: Post-Brussels conference financial tracking

The G200 Youth Forum 2015 has 4 main platforms which will run in tandem with each other:

Slide 1. Slide 2 Learning Objectives. Grantwriting and Budgeting for Public Health Programs

The Lisbet Rausing Charitable Fund

March 9, Honourable Winston Dookeran Minister of Finance Eric Williams Finance Building Independence Square Port of Spain Trinidad and Tobago

Transcription:

tracking microbicide funding Polly F. Harrison, PhD Director, Alliance for Microbicide Development Satellite Meeting: Resource Tracking & Priority Setting XV International AIDS Conference, Bangkok 11 July 2004-9:30-11:30am

methodology (overview)! track 3 major sectors US public sector international public sector philanthropic sector! methodological style! methodological structure record actual annual expenditures estimate current fiscal year expenditures

overview of funding for microbicide R&D by sector, 2002 Philanthropic Sector 12% International Public Sector 35% US Public Sector 53% Total: $141.8

overview of funding for microbicide R&D by sector, 1997-end 2003 (cumulative) Philanthropic Sector Support 16% International Public Sector Support 14% Total: $483.6 US Public Sector Support 70%

SOURCE 1997 1998 1999 2000 2001 2002 2003 Cum. 2004 (actual) (actual) (actual) (actual) (actual) (actual) (actual) ('97-'03) (estimate) PUBLIC SECTOR SUPPORT UNITED STATES Centers for Disease Control and Prevention (CDC) CDC TOTAL: 3,969,283 3,428,000 4,039,502 2,377,062 2,221,031 4,488,722 2,972,000 23,495,600 3,406,000 National Institutes of Health (NIH) NIAID 13,124,804 13,545,000 18,118,134 18,759,000 27,161,000 36,648,000 36,062,000 163,417,938 39,824,000 NICHD 6,344,099 5,150,000 7,732,859 8,305,000 14,255,000 14,100,000 14,970,000 70,856,958 16,500,000 ORWH 100,000 1,000,000 - - - - - 1,100,000 NIDA 106,821 - - - 960,000 580,000 1,485,000 3,131,821 1,543,000 NCI - - - 563,000 46,000 42,000 521,000 1,172,000 526,000 NINR - - - 357,000 818,000-341,000 1,516,000 348,000 NIMH - - - 1,284,000 2,065,000 1,259,000 2,561,000 7,169,000 2,653,000 NCRR - - - 190,000 400,000 1,238,000 924,000 2,752,000 955,000 FIC 100,000 100,000 108,593 115,000 850,000 928,000 634,000 2,835,593 650,000 OD 957,999 - - 901,000 490,000 997,000 411,000 3,756,999 395,000 NIH TOTAL: 20,733,723 19,795,000 25,959,586 30,474,000 47,045,000 55,792,000 57,909,000 257,708,309 63,394,000 United States Agency for Int'l Development (USAID) USAID TOTAL: 2,100,000 2,100,000 2,300,000 1,784,430 12,000,000 15,000,000 17,890,000 53,174,430 22,000,000 UNITED STATES TOTAL: 26,803,006 25,323,000 32,299,088 34,635,492 61,266,031 75,280,722 78,771,000 334,378,339 88,800,000 INTERNATIONAL Canada Funder: Canadian Institute for Health Research Laval University - - - - - - - - 2,800,000 Funder: Canadian Int'l Development Agency Laval University - - 350,000 - - - - 350,000 - CANADA TOTAL: - - 350,000 - - - - 350,000 2,800,000 Denmark Funder: Danish Government IPM - - - - - 136,929 637,426 774,355 - DENMARK TOTAL: - - - - - 136,929 637,426 774,355 - France Funder: French Government ANRS - - - - - 41,800,000-41,800,000 - FRANCE TOTAL: - - - - - 41,800,000-41,800,000 - Ireland Funder: Ireland AIDS IPM - - - - - 980,000 2,832,250 3,812,250 2,802,000 IRELAND TOTAL: - - - - - 980,000 2,832,250 3,812,250 2,802,000

SOURCE 1997 1998 1999 2000 2001 2002 2003 Cum. 2004 (actual) * (actual) (actual) (actual) (actual) (actual) (actual) ('97-'03) (estimate) PUBLIC SECTOR SUPPORT INTERNATIONAL Netherlands Funder: Dutch Government IPM - - - - - 490,000 1,835,100 2,325,100 2,450,000 NETHERLANDS TOTAL: - - - - - 490,000 1,835,100 2,325,100 2,450,000 Norway Funder: Norwegian Government IPM - - - - - 696,334 746,411 1,442,745 1,487,830 NORWAY TOTAL: - - - - - 696,334 746,411 1,442,745 1,487,830 United Kingdom Funder: Department for Int'l Development (DfID) 1 IPM - - - - - 468,812 510,150 978,962 550,290 MRC - - - - - 4,590,400 4,590,400 9,180,800 4,590,400 Funder: European Union 2 Empro Project - - - - - - - - - DABO (Idenix) - - - - - - 8,624,000 8,624,000 2,711,500 UNITED KINGDOM TOTAL: - - - - - 5,059,212 13,724,550 18,783,762 7,852,190 United Nations Funder: UNFPA IPM - - - - - 100,000-100,000 - UNITED NATIONS TOTAL: - - - - - 100,000-100,000 - World Bank IPM - - - - - 145,000-145,000 225,000 WORLD BANK TOTAL: - - - - - 145,000-145,000 225,000 INTERNATIONAL TOTAL 3 : - - 350,000 - - 49,407,475 19,775,737 69,533,212 34,786,044 PUBLIC SECTOR (US + INT'L) TOTAL: 26,803,006 25,323,000 32,649,088 34,635,492 61,266,031 124,688,197 98,546,737 403,911,551 123,586,044

SOURCE 1997 1998 1999 2000 2001 2002 2003 Cum. 2004 (actual) * (actual) (actual) (actual) (actual) (actual) (actual) ('97-'03) (estimate) PHILANTHROPIC SECTOR SUPPORT American Foundation for AIDS Research (amfar) U.of Geneva - - - - - - 90,000 90,000 - NYU School of Medicine - - - - - - 99,000 99,000 - CDC - - - - 88,200 99,000-187,200 - Ruth Ben-Ari Institute - - - - 87,600 - - 87,600 - Yale U. School of Medicine - - - - 90,000 - - 90,000 - Duke U. - - - - 90,000 - - 90,000 - Imperial College of Science, Tech, Med - - - - 89,994 - - 89,994 - Others - - 875,000 - - - - 875,000 - amfar TOTAL: - - 875,000-445,794 99,000 189,000 1,608,794 - Bill and Melinda Gates Foundation EVMS - 1,500,000 - - - 12,000,000-13,500,000 - GMP - - - 25,000,000 - - - 25,000,000 - IPM - - - - - - 9,599,742 9,599,742 13,087,521 Population Council - 450,000 4,000,000-4,000,000 4,000,000 4,000,000 16,450,000 4,000,000 GATES FOUNDATION TOTAL: - 1,950,000 4,000,000 25,000,000 4,000,000 16,000,000 13,599,742 64,549,742 17,087,521 William and Flora Hewlett Foundation Alliance for Microbicide Development - - 75,000-175,000 - - 250,000 60,000 HEWLETT TOTAL: - - 75,000-175,000 - - 250,000 60,000 Moriah Fund Alliance for Microbicide Development - - - - 213,000 - - 213,000 - Global Campaign for Microbicides - - - - 71,000 - - 71,000 - MORIAH FUND TOTAL: - - - - 284,000 - - 284,000 - Rockefeller Foundation 3 IPM - - - - - 1,010,236 4,013,944 5,024,180 2,250,000 Others 1,422,400 1,375,000 102,600 1,938,920 3,116,080 - - 7,955,000 - ROCKEFELLER TOTAL: 1,422,400 1,375,000 102,600 1,938,920 3,116,080 1,010,236 4,013,944 12,979,180 2,250,000 PHILANTHROPIC TOTAL: 1,422,400 3,325,000 5,052,600 26,938,920 8,020,874 17,109,236 17,802,686 79,671,716 19,397,521 GRAND TOTAL: 28,225,406 28,648,000 37,701,688 61,574,412 69,286,905 141,797,433 116,349,423 483,583,267 142,983,565 Source: Lamphear TL. Funding for Microbicides: An Overview Chart. Silver Spring, Maryland, USA: Alliance for Microbicide Development, July 2004.

what we think we have! estimates for FY2004 US public sector $88.8 million int l public sector $34.8 million philanthropic sector $19.4 million estimated total = $143.0 million

future plans for microbicide tracking! transition from macro to micro level basic science preclinical development clinical development microbicide education, advocacy, & policy development! establish formal annual report of findings (blueprint? coordination w/ vaccines?)

what we need: respondents & cost ranges! preclinical-3 developers, range $400k-4M! phase 1-16 developers, range $300k-4M! phase 2-4 developers, range $2M-5M! phase 3-10 developers, range $9M-50M

challenges & issues! international tracking gaps! timely congressionally-mandated reports to Congress (US public sector)! need for standardized reporting back from all sectors

next steps for tracking investment in new HIV prevention technologies! increased collaboration among institutions tracking investments! countries funding prevention technologies, &! philanthropic organizations funding prevention technologies, start to track their spending! options being explored to improve estimates of industry funding! all funders provide information on their funding allocations by type of activity & geographic location

acknowledgments Franka N. des Vignes, PhD Program Officer Trisha L. Lamphear, MPH Research Associate Jana C. Bowcut, MPH Research Associate Cecilia D. Fox Administrative Associate Pamela Norick Senior Legislative & Policy Adviser The work of the Alliance has been made possible by the dedication of its participants & contributions from the: William & Flora Hewlett Foundation International Partnership for Microbicides Moriah Fund Rockefeller Foundation Bill & Melinda Gates Foundation through the Global Microbicide Project & the generosity of private contributors.

for more information www.microbicide.org or contact the Alliance directly: 8484 Georgia Avenue, Suite 940 Silver Spring, MD, USA 20910 tel: 301-587-9690; fax: 301-588-8390 email: info@microbicide.org